Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine

NCT00593606 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Rotigotine

Sponsor

UCB Pharma